ID: ALA1160011

Max Phase: Preclinical

Molecular Formula: C5H10O3

Molecular Weight: 118.13

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): 2-Hydroxymethyl-Butyric Acid Anion
Synonyms from Alternative Forms(1):

    Canonical SMILES:  CCC(CO)C(=O)O

    Standard InChI:  InChI=1S/C5H10O3/c1-2-4(3-6)5(7)8/h4,6H,2-3H2,1H3,(H,7,8)

    Standard InChI Key:  ZMZQVAUJTDKQGE-UHFFFAOYSA-N

    Associated Targets(Human)

    L-xylulose reductase 11 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: YesOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 118.13Molecular Weight (Monoisotopic): 118.0630AlogP: 0.09#Rotatable Bonds: 3
    Polar Surface Area: 57.53Molecular Species: ACIDHBA: 2HBD: 2
    #RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
    CX Acidic pKa: 4.51CX Basic pKa: CX LogP: 0.18CX LogD: -2.61
    Aromatic Rings: 0Heavy Atoms: 8QED Weighted: 0.55Np Likeness Score: 1.05

    References

    1. Carbone V, Darmanin C, Ishikura S, Hara A, El-Kabbani O..  (2003)  Structure-based design of inhibitors of human L-xylulose reductase modelled into the active site of the enzyme.,  13  (8): [PMID:12668014] [10.1016/s0960-894x(03)00166-5]

    Source